Biotech

All Articles

Former Seagen CEO reveals brand-new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was actually marketed to Pfizer in 2013 for a...

Ironwood makes additional purpose $1B GI medication with brand-new subgroup records

.On the heels of a stage 3 gain that failed to blow away entrepreneurs, Ironwood Pharmaceuticals is ...

Novartis inks $150M bargain for autoimmune molecular adhesive

.Don't cease Monte Rosa Rehabs right now. The Boston-based biotech is enjoying after authorizing a h...

Jade carves out director group along with Chinook vets-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of substantial leadership hirings, firings a...

Septerna goes public with upsized offering of $288M

.Commemorating his firm's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer rang the...

AbbVie creates Richter wealthier, paying $25M to create discovery contract

.AbbVie has returned to the resource of its own antipsychotic powerhouse Vraylar searching for yet a...

GenSight enters ultimate full weeks of cash money path as revenue flow squeezes by of scope

.GenSight Biologics is actually weeks off of losing funds. Once again. The biotech only has sufficie...

AZ licenses thrown away unusual illness medication to Monopar Rehabs

.Monopar Therapeutics is recovering a medicine coming from the scrap heap of AstraZeneca's rare ailm...

Arcus' brand new HIF-2a information in kidney cancer hint at potential edge over Merck's Welireg, analysts say

.Along with brand-new data out on Arcus Biosciences' speculative HIF-2a prevention, one team of prof...

Roche wagers as much as $1B to broaden Dyno gene therapy shipping treaty

.After forming a gene treatment partnership with Dyno Therapies in 2020, Roche is back for more.In a...